Invisible-Light Labs Closes $1.6M Pre-Seed Round Led by XISTA Science Ventures and Aws Gründungsfonds

Why It Matters

The investment propels a breakthrough nanoscale spectroscopy tool toward market adoption, addressing a critical analytical gap in high‑growth sectors such as pharmaceuticals, environmental health and semiconductor manufacturing.

Key Takeaways

• €1.5M (~$1.6M) pre‑seed round led by XISTA and aws Gründungsfonds.
• EMILIE combines nanomechanical sensing with FTIR for picogram‑level analysis.
• Co‑marketing with Bruker expands global reach of the NEMS‑FTIR system.
• Targets pharma, environmental monitoring, nanomaterials, and semiconductor sectors.
• Part of €60.5M (~$64.7M) 2026 European DeepTech funding wave.

Pulse Analysis

The ability to chemically identify particles smaller than a micron is becoming a bottleneck for several high‑growth industries. Traditional spectroscopic tools struggle with the minute sample masses required for nanomaterials, nanoplastics, and emerging drug delivery vectors. By delivering picogram‑level sensitivity, Invisible‑Light Labs’ NEMS‑FTIR platform promises to close that gap, enabling faster R&D cycles and more reliable compliance testing. As regulators tighten standards on airborne nanoparticles and pharmaceutical purity, the market for ultra‑sensitive, easy‑to‑use analyzers is set to expand rapidly.

The startup’s flagship instrument, EMILIE, merges nano‑electromechanical resonators with Fourier‑transform infrared spectroscopy, a combination that yields chemical fingerprints from sub‑micron particles in seconds. Co‑branded with Bruker Optics, the system leverages Bruker’s global sales network while retaining the proprietary sensing core developed at TU Wien. Early adopters span pharmaceutical firms seeking trace‑level impurity detection, environmental agencies monitoring aerosol composition at remote stations, and semiconductor manufacturers requiring contamination control. The recent €1.5 million (≈$1.6 million) pre‑seed injection will accelerate production scaling and broaden the product roadmap.

Invisible‑Light Labs joins a wave of European university‑spun DeepTech ventures that have collectively secured about €60.5 million (≈$64.7 million) in 2026 funding across nanomaterials, photonics and quantum hardware. While the round is modest compared with later‑stage raises at Chiral or Groove Quantum, it underscores investor confidence in moving specialized physical technologies from the lab to market. For investors, the deal signals a fertile niche where scientific rigor meets commercial demand, and for the industry it marks a step toward routine nanoscale chemical analysis.

Deal Summary

Vienna-based Invisible-Light Labs, a deep‑tech spin‑off from TU Wien, closed a $1.6M pre‑seed round to accelerate commercialization of its infrared analysis platform EMILIE. The round was co‑led by XISTA Science Ventures and aws Gründungsfonds, with participation from Fund F. The funding will support product development for environmental monitoring, pharmaceutical analysis, and nanotechnology applications.